Top Markets
Coin of the day
Comera Life Sciences Holdings, Inc. Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

CMRAW
Rangering i aksjer #41593
Comera Life Sciences Holdings, Inc. is an early-stage life sciences company... Comera Life Sciences Holdings, Inc. is an early-stage life sciences company dedicated to developing its own innovative therapeutics. These treatments leverage its unique SQore formulation platform, which is engineered to convert biologics typically administered intravenously (IV) into convenient subcutaneous (SQ) versions. The company's pipeline currently features two primary drug candidates: CLS-001, an improved biologic in preclinical development, targets Crohn's and Ulcerative Colitis; and CLS-002, also in preclinical stages, is an enhanced biologic aimed at various oncological indications. Established in 2014, Comera Life Sciences is based in Woburn, Massachusetts.
Aksjekurs
$0.0008
Sist synkronisert: 2024-03-14
Markedsverdi
$15.27K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Comera Life Sciences Holdings, Inc. (CMRAW)

Kategori

P/S-forhold for Comera Life Sciences Holdings, Inc. (CMRAW)
P/S-forhold per 2026 TTM: 0
Ifølge Comera Life Sciences Holdings, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Comera Life Sciences Holdings, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR